Perinatal depression is depression during pregnancy or in the weeks and months after birth. Federal health agencies say it can be treated and that help exists, which makes outreach worth doing and easy to do badly. A page can frighten a new parent with a statistic, promise that a program will prevent depression, push a medicine by name, blur the baby blues with a condition that needs care, or skip the crisis line. A reminder can tell a partner, a parent or a roommate about a mood visit the patient has not discussed with anyone. This guide covers how an OB-GYN practice, a midwife or birth center, a pediatric practice, a primary care practice, a community health center or a behavioral health practice can invite pregnant and postpartum patients to talk about mood on the federal sources as written, say plainly that the USPSTF update is not final yet, put 988 and 911 in every tool, keep screening apart from diagnosis and from coverage, and write calm, private pages and messages.
Ten related topics have their own guides and are not repeated here. The practices that care for patients in pregnancy and after birth are covered in our guides to OB-GYN practice marketing, maternal-fetal medicine practice marketing, doula, midwife and birth center marketing, lactation consultant marketing and pediatric practice marketing. Mental health care is covered in our guides to depression screening outreach, behavioral health integration outreach, therapist private practice marketing and psychiatric practice marketing. Care for patients with Medicaid is covered in our guide to marketing to Medicaid patients.
This is general information, not legal or medical advice. Sources cited were checked on October 30, 2026: the USPSTF final recommendation Perinatal Depression: Preventive Interventions (February 12, 2019), its draft update and draft evidence review (April 22, 2025), the USPSTF Recommendations in Progress page, the USPSTF final recommendation Depression and Suicide Risk in Adults: Screening (June 20, 2023), the HHS announcement of new Task Force members (September 17, 2026) posted on the USPSTF site, the Supreme Court decision in Kennedy v. Braidwood Management (June 27, 2025), the NIMH page Perinatal Depression (revised 2023), the CDC page Symptoms of Depression Among Women (May 14, 2024), read through an archived copy, the MedlinePlus page Postpartum Depression, the FDA announcement of August 4, 2023, the AAP and Bright Futures Recommendations for Preventive Pediatric Health Care (updated February 2025), 42 U.S.C. 300gg-13 and 42 U.S.C. 1396a(e)(16). Medical advertising rules are also set state by state. Check them with your counsel before a campaign runs.
What the federal sources say
The USPSTF rates preventive services, NIMH, CDC and MedlinePlus explain the condition to patients, FDA reviews medicines, and federal law ties some preventive services to coverage. The points that shape perinatal depression outreach:
- The USPSTF final recommendation Perinatal Depression: Preventive Interventions (February 12, 2019) recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions (grade B). It applies to pregnant persons and persons less than 1 year postpartum who do not have a current diagnosis of depression. It says there is no accurate screening tool for identifying who is at risk, and it names risk factors such as a personal or family history of depression, current depressive symptoms that do not reach a diagnostic threshold, low income, adolescent or single parenthood and recent intimate partner violence. It found limited or mixed evidence for other studied approaches, including medicine, supplements, physical activity and education.
- The USPSTF posted a draft update with a draft evidence review dated April 22, 2025. The draft recommends that clinicians provide or refer those at increased risk of perinatal depression to counseling interventions during pregnancy and the postpartum period, says it is consistent with the 2019 recommendation, and keeps the grade B. Public comments are closed. On October 30, 2026, the Recommendations in Progress page listed the topic at the stage of finalizing the recommendation statement.
- The USPSTF final recommendation Depression and Suicide Risk in Adults: Screening (June 20, 2023) recommends screening for depression in the adult population, including pregnant and postpartum persons (grade B). Our guide to depression screening outreach covers that recommendation in full.
- The NIMH page Perinatal Depression (revised 2023) says perinatal depression includes depression during pregnancy and in the weeks and months after childbirth, and that it can be treated. It says the baby blues are mild, short-lasting mood changes in the first 2 weeks after giving birth, and that mood changes and feelings of anxiety or unhappiness that are severe or last longer than 2 weeks after childbirth may be signs of postpartum depression. It calls postpartum psychosis a psychiatric emergency and says a person with its symptoms should call 911 or go to the nearest emergency room.
- The CDC page Symptoms of Depression Among Women (May 14, 2024, read through an archived copy) says CDC research shows about 1 in 8 women with a recent live birth reported symptoms of postpartum depression, names a previous or family history of depression and little or no social support as risk factors, and tells a person who thinks they have postpartum depression to seek treatment from their health care provider as soon as possible. In a crisis, it gives 911 and 988.
- The MedlinePlus page Postpartum Depression (checked October 30, 2026) says that a person with thoughts about suicide or about hurting themselves or their baby should get help right away by calling 911 or going to the local emergency room or contacting a crisis line, gives the 988 Suicide and Crisis Lifeline, and says to call 911 or go to the nearest emergency room right away for symptoms of postpartum psychosis.
We checked for changes before writing. The 2019 page carries an update in progress notice, and the 2025 draft was listed at the finalizing stage on October 30, 2026, with no final update posted; we could not confirm developments after that date. The NIMH page was revised in 2023 and names one medicine FDA approved for severe postpartum depression. A newer FDA announcement, dated August 4, 2023, reports the approval of the first oral medicine for postpartum depression in adults, and current FDA labels list two medicines for postpartum depression. We do not name them here, and a marketing page should not either. The CDC page was read through an archived copy, since the CDC site did not answer our direct requests. A practice page should quote the sources in force on the day it is written, say that the USPSTF update is not final if it still is not, and record that date in its review notes.
The Task Force itself has changed. In Kennedy v. Braidwood Management, decided June 27, 2025, the Supreme Court held that Task Force members are inferior officers whose appointment by the Secretary of HHS is consistent with the Appointments Clause. On September 17, 2026, HHS announced eight new members who join the eight already serving. The perinatal draft was posted before that change, so check the USPSTF page again before a campaign runs: the final version may differ from the draft.
Two points shape the marketing. First, the USPSTF recommends counseling for people at increased risk, not a product, a medicine or a program by name: a page can say the practice asks about mood and refers to counseling, and should not promise to prevent depression. Second, a screening answer is not a diagnosis: a set of questions about mood starts a conversation, and the clinician decides with the patient what it means and what comes next. A page that turns a score into a verdict overstates the screening.
Perinatal depression pages and claims that need rewriting
Google’s search suggestions, which we checked on October 30, 2026, offer “postpartum depression symptoms”, “postpartum depression vs psychosis”, “postpartum depression in men”, “postpartum depression screening” and “postpartum depression treatment” to a person who types “postpartum depression”. For “perinatal depression” they offer “perinatal depression vs postpartum depression” and “perinatal depression screening”, and for “postpartum depression help” they offer “postpartum depression help near me” and “postpartum depression support”. For “postpartum depression therapist” they offer “postpartum depression therapist near me”, “postpartum depression therapist online” and “postpartum depression therapist medicaid”. Suggestions change with time and place, and they show what people type, not how they feel. The searches show people looking for help, a therapist, an online option and a way to pay, and trying to tell postpartum depression apart from psychosis.
A page that holds up says in plain words that mood changes in pregnancy and after birth are worth raising, explains the difference between the baby blues and depression as NIMH does, says who the patient talks to and how referrals to counseling work, gives 988 and 911 near the top, states coverage with its conditions, names no medicine, and offers the page in the languages the practice’s patients speak.
Phrases that need rewriting:
- “1 in 8 new moms get postpartum depression. Will you be next?” A statistic used to alarm. If the page uses the figure, quote CDC by name and date, and pair it with what the reader can do: tell the care team how they are feeling.
- “Our program prevents postpartum depression.” A promise with no source. The USPSTF recommends counseling for people at increased risk; say the practice offers or refers to counseling, and promise no result.
- “Ask us about the new pill for postpartum depression.” A medicine pushed on a marketing page. Name no medicine; treatment choices belong to the clinician and the patient.
- “It’s just the baby blues. It will pass.” NIMH says mood changes that are severe or last longer than 2 weeks after childbirth may be signs of postpartum depression. Say that, and invite the reader to talk to the care team.
- “Take our 2-minute quiz to find out if you have postpartum depression.” A screening answer is not a diagnosis. If the page offers questions, say a clinician reviews the answers with the patient, and give 988 and 911 next to them.
- “Free postpartum therapy.” Coverage depends on the payer, the plan and the service. State the conditions, or say the practice checks coverage first.
- “Our moms feel like themselves again in 6 weeks.” A result with no source, and a claim about other patients. Remove it unless it comes from the practice’s own documented and reviewed records, with its date and limits stated.
Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting the federal sources as written, with each one named and dated, stays inside that standard; turning a federal statement into a promise to a patient does not.
988 and 911 in every tool
A perinatal depression page reaches people in distress, and some will read it at night with a newborn. Put two plain lines near the top of the page, on flyers, in reminders and in the footer of the booking page: if you are struggling or having thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline; if you or your baby are in danger, or you have a medical emergency, call 911 or go to the nearest emergency room. NIMH and MedlinePlus give 911 or the nearest emergency room for symptoms of postpartum psychosis, and NIMH, CDC and MedlinePlus give 988.
The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools. A tool should give 988 and 911 at once to any message about suicide, self-harm, harm to a baby or an emergency and alert staff, route questions about mood, symptoms or medicines to a clinician, and never tell a person whether they have depression, whether a feeling is normal, or whether to start or stop a medicine while pregnant or breastfeeding. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.
Who to invite: pregnancy, after birth and the infant visits
Patients come to a conversation about mood through different visits, and each needs its own wording.
Keep these points:
- Pregnant patients: the USPSTF 2023 adult recommendation includes pregnant persons in depression screening, and the 2019 recommendation adds counseling for those at increased risk. A prenatal page can say the care team asks about mood at visits and can refer to counseling.
- After birth: the 2019 recommendation covers persons less than 1 year postpartum. A postpartum page can invite patients to raise mood at the postpartum visit or sooner, and say how to reach the care team between visits.
- Parents at the baby’s visits: the AAP and Bright Futures Recommendations for Preventive Pediatric Health Care (updated February 2025) list maternal depression screening at the 1, 2, 4 and 6 month visits. A pediatric page can say the team asks the parent how they are doing and helps them reach their own clinician.
- People at increased risk: the USPSTF names risk factors, but it also says there is no accurate tool for finding who is at risk. Invite everyone in the practice’s care to raise mood, and leave the judgment of risk to the clinician.
- Partners and other parents: people search for postpartum depression in men. The USPSTF recommendation covers pregnant and postpartum persons; a page can tell partners to raise their own mood with their own clinician, and give them 988 and 911 too.
- People with a current diagnosis: they need care, not a screening slot. Point them to the practice’s behavioral health team or to a therapist or psychiatric practice.
- Public ads: invite by stage, such as pregnancy or the months after birth, and do not single out a group by age, income, marital status, background or neighborhood, even though some of these appear among the USPSTF risk factors.
Our guides to OB-GYN practice marketing and pediatric practice marketing cover the wider rules for those pages.
After the screening: counseling, referral and follow-up
A screening answer leads to a conversation, not a label. A page should describe the next steps in plain words and in the practice’s own terms: who reviews the answers, how the patient hears about them, how a referral to counseling works, how long a wait is likely to be if the practice knows it, and that the patient decides with the clinician what comes next. The USPSTF describes counseling delivered in groups or one to one, in person, by psychologists, midwives, nurses and other mental health professionals; a page can say which of these the practice offers or refers to, without naming a program it does not run.
Some patients need a therapist or a psychiatric clinician. The page can say the practice refers patients when the clinician judges it needed, that patients can choose among clinicians where more than one is available, and whether visits by video are offered; our guide to telehealth marketing for practices covers that. Do not name medicines, doses or treatment courses on a marketing page, and do not promise that treatment will work by a certain date; treatment choices belong to the clinician and the patient. CDC tells patients to tell their provider if they are pregnant, planning a pregnancy or breastfeeding when discussing medicines, and that decision is for the visit, not the ad.
Coverage: preventive rules, Medicaid and the infant visits
Under 42 U.S.C. 300gg-13, group health plans and health insurers must cover, without cost sharing, services with a USPSTF A or B rating in effect. The 2019 counseling recommendation and the 2023 depression screening recommendation are both grade B, so that rule applies to those services as the plan applies them, and the details depend on the plan, the network and how the visit is billed. The same section also ties coverage for infants, children and adolescents to the HRSA supported comprehensive guidelines; how a plan handles a parent’s screening at the baby’s visit depends on the plan. Keep the recommendation and the coverage apart on the page, and say the practice checks coverage first.
Medicaid matters in pregnancy and after birth. Under 42 U.S.C. 1396a(e)(16), a state may choose to keep a person who received Medicaid while pregnant eligible through the end of the month in which a 12-month postpartum period ends. Whether a state has done so, and which mental health services its plan covers, is set state by state; a page should say the practice can help patients check their coverage, not promise a year of free care. Our guide to marketing to Medicaid patients covers the wider rules.
A free support group or a gift for coming in follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. A baby gift or a gift card for coming in needs counsel’s review before it runs.
Products, apps and supplements sold alongside
A practice may be offered mood apps, supplements, teas or wellness kits to sell or promote next to its postpartum program. The USPSTF found limited or mixed evidence that approaches other than counseling, including supplements, prevented perinatal depression. The FDA Questions and Answers on Dietary Supplements says supplements are not intended to treat, diagnose, mitigate, prevent or cure diseases. Do not present a product, an app or a supplement as a way to prevent or treat postpartum depression, name no brand, and have counsel review any product partnership. An app that collects mood answers also raises the privacy points below.
Recall texts, letters and reminders
Pregnant and postpartum patients hear from the practice about prenatal visits, the postpartum visit, the baby’s visits and follow-up after a referral. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended service, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508.
The words in the message matter as much as the rule. A text, a postcard or a voicemail can be seen by a partner, a parent, a roommate or an employer, and some patients live with a person who harms them. Keep these points:
- Invite to the visit, not to the topic: “[Practice name]: you are due for a visit. Call [phone] or reply to book.” A reminder for a counseling or follow-up visit should not say what the visit is for.
- Never put depression, mood, a screening answer, a referral to a mental health clinician or a diagnosis in a text, a postcard, a voicemail or an email subject line; share them through the portal or a call, as the practice’s protocol says.
- Use the contact method and number the patient chose, ask whether it is safe to leave messages there, and keep the caller ID and the sender name neutral.
- For a patient who is a minor, follow the practice’s protocol and 45 CFR 164.502(g), which defers to state and other law on when a parent acts as a minor’s personal representative.
- Give every message an easy opt-out, and honor it.
Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.
Partners, families and caregivers
Partners and relatives book visits, bring the baby in and may call to say they are worried. Under 45 CFR 164.510(b), a covered entity may share information relevant to a family member’s or friend’s involvement in a patient’s care when the patient agrees or does not object, or, when the patient is not present or cannot agree, when the professional judges it is in the patient’s best interest. The intake team should ask the patient what may be shared and with whom, and record it. A page can tell partners and relatives what signs NIMH describes and how to reach the care team or 988 and 911, and staff should take a worried relative’s call seriously while still following the patient’s recorded wishes about what is shared back.
Partners, counselors and referral payments
Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state.
For a perinatal mental health program, keep these points:
- Do not accept payment from a therapist, a group practice, a telehealth company, an app maker or a drug maker for the patients the practice sends them, and do not pay a doula, a lactation consultant, a birth center or a community group per person referred, without counsel’s review.
- Give patients more than one counseling option where they exist, and tell them they can choose; our guide to patient and physician referrals covers referral rules.
- A shared care arrangement with a behavioral health practice should be set out in writing and reviewed by counsel; our guide to behavioral health integration outreach covers the in-practice model.
Privacy, pixels and ads
A booking for a mood visit, a screening answer, a page about postpartum depression or a page that shows a person is pregnant can say something sensitive about a person’s health. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. Do not put screening questions on a public web form that sends answers by email or to an ad tool. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place, language settings and search terms such as “postpartum depression help near me”, and should not be built from a list of pregnant or postpartum patients or of patients with a mental health diagnosis taken from the practice’s records. Ad copy should not address the reader as a person who has depression.
Tone, access and patient stories
A new parent who feels judged may hide how they feel rather than raise it. Present the conversation about mood as part of routine care in pregnancy and after birth, use calm, kind words, and keep out alarm and blame: no images of a crying parent with a baby in a screening ad, no wording that suggests a parent who struggles is failing their child, and no wording that suggests a parent will be reported for saying how they feel. Write in plain words, offer the page in the languages the practice’s patients speak, and link the translated versions of federal pages where they exist; NIMH and MedlinePlus offer pages in Spanish. The Department of Justice Guidance on Web Accessibility and the ADA describes website features such as text alternatives, enough color contrast and the ability to resize text that help people with disabilities use a site; our guide to Spanish language medical marketing covers translation.
A parent’s story about getting help can encourage others. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. Use a story only if the patient chose to share it in writing, get a signed authorization under 45 CFR 164.508 where the practice is a covered entity, leave out the baby’s face and name unless the parent chose to share them, say if the patient received anything for taking part, let them review the final version, and let them withdraw it later. Our guides to patient photo consent and testimonials and before and after photos cover the full rules.
Illustration: two postpartum messages
Illustration: a flyer reads “1 in 8 new moms get postpartum depression. Don’t let it steal your baby’s first year! Our program prevents it, and our 2-minute quiz tells you if you have it. Ask about the new pill. Free therapy for new moms. Our moms feel like themselves again in 6 weeks.” It uses a statistic to frighten, promises prevention, turns a quiz into a diagnosis, pushes a medicine, makes a free claim with no conditions, claims a result with no source, and gives no 988 or 911 line.
Illustration: a second flyer for the same practice reads “At [Practice name], we ask about mood during pregnancy and in the year after birth. Feeling low, worried or not like yourself for more than 2 weeks after birth is worth raising, and our team can talk with you and refer you to counseling. We check your coverage first. If you are struggling or having thoughts of suicide, call or text 988. If you or your baby are in danger, call 911. To book, call [phone], [days and hours].” It follows NIMH on the 2 week point, describes the next step plainly, keeps coverage conditional and gives 988 and 911.
Checklist before a perinatal depression campaign goes live
- Copy built on the USPSTF 2019 and 2023 recommendations, the NIMH, CDC and MedlinePlus pages, each named and dated; the 2025 draft described as a draft and the update as not final; the sources checked again on the day the page is written, with the date recorded.
- Any statistic quoted with its source and date and paired with a next step; no alarm, no images of a parent in distress, no wording that blames a parent.
- Screening kept apart from diagnosis; counseling described as an offer or a referral; no promise to prevent or cure depression and no medicine names, doses or product names.
- 988 and 911 on pages, flyers, voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools; mood, symptom and medicine questions routed to a clinician.
- Invitations by stage of pregnancy or care, not by income, age, marital status or background; people with a current diagnosis sent to care.
- Coverage described as 42 U.S.C. 300gg-13 and 42 U.S.C. 1396a(e)(16) state it, with plan and state coverage checked per patient; free groups and gifts reviewed under 16 CFR 251.1 and 42 U.S.C. 1320a-7a(a)(5).
- Reminders, postcards, caller ID names, voicemails and subject lines carry no mention of mood, depression, screening answers or referrals; the patient asked whether messages are safe.
- Partner and family calls handled under the patient’s recorded wishes.
- No app, supplement or product claims; no payments to or from counselors, telehealth companies, app or drug makers or community partners without counsel’s review under the anti-kickback statute; patient stories with signed authorizations.
- Screening answers, pregnancy status and patient lists stay out of web forms sent by email, ad audiences and tracking tools; the page offered in the languages the practice’s patients speak and checked against the ADA web guidance.
Screening for intimate partner violence in pregnant and postpartum patients, safe reminders and confidential contact requests are covered in our guide to intimate partner violence screening outreach.
How we help
We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including OB-GYN practices, midwives and birth centers, pediatric practices and behavioral health practices. For a perinatal mental health program, that means a site that builds its pages on the USPSTF, NIMH and CDC pages as written and dated, says plainly that the USPSTF update is not final, keeps screening apart from diagnosis and both apart from coverage, gives 988 and 911 where a reader in distress will see them, and answers “postpartum depression help near me” and “postpartum depression therapist” searches calmly and honestly, plus appointment request pages that book a visit without asking about mood on the web and keep answers away from tracking tools. Our front desk tools give 988 and 911 at once to any message about suicide, self-harm, harm to a baby or an emergency and alert staff, route mood and medicine questions to a clinician, and do not tell anyone whether they have depression. We do not decide who should be screened or treated; your clinicians and patients do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.
What does the USPSTF recommend for perinatal depression?
Its final recommendation of February 12, 2019 says clinicians should provide or refer pregnant and postpartum persons at increased risk of perinatal depression to counseling interventions (grade B). A draft update with a draft evidence review dated April 22, 2025 keeps the grade B and was listed at the finalizing stage on October 30, 2026. Check the USPSTF page before a campaign runs.
Does the USPSTF recommend depression screening in pregnancy?
Yes. Its June 20, 2023 recommendation on depression in adults includes pregnant and postpartum persons (grade B). The 2019 perinatal recommendation adds counseling for those at increased risk. Quote both with their dates.
How should our page explain the baby blues?
Follow NIMH: the baby blues are mild, short-lasting mood changes in the first 2 weeks after birth, and mood changes that are severe or last longer than 2 weeks after childbirth may be signs of postpartum depression. Invite the reader to talk to the care team either way.
Which crisis lines should the page give?
Two lines: call or text 988, the Suicide and Crisis Lifeline, for anyone struggling or having thoughts of suicide, and call 911 or go to the nearest emergency room in an emergency, including symptoms of postpartum psychosis, as NIMH and MedlinePlus say.
Can our page mention the medicines FDA has approved for postpartum depression?
Keep medicines off marketing pages. FDA has approved medicines for postpartum depression, but treatment choices belong to the clinician and the patient at the visit. The page can say the care team explains the treatment options.
Can our reminder text mention the postpartum mood visit?
No. Invite the patient to a visit, and never put mood, depression, a screening answer or a referral in a text, postcard, voicemail or subject line. Use the contact method the patient chose and ask whether messages there are safe.
Sources
- USPSTF: Perinatal Depression: Preventive Interventions (February 12, 2019)
- USPSTF: Draft Recommendation: Perinatal Depression: Preventive Interventions (draft evidence review April 22, 2025)
- USPSTF: Recommendations in Progress (checked October 30, 2026)
- USPSTF: Depression and Suicide Risk in Adults: Screening (June 20, 2023)
- HHS: Secretary Kennedy Announces New Appointments to U.S. Preventive Services Task Force (September 17, 2026)
- Kennedy v. Braidwood Management, Inc. (U.S. Supreme Court, decided June 27, 2025)
- NIMH: Perinatal Depression (revised 2023)
- CDC: Symptoms of Depression Among Women (May 14, 2024)
- MedlinePlus: Postpartum Depression (checked October 30, 2026)
- FDA: FDA Approves First Oral Treatment for Postpartum Depression (August 4, 2023)
- FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
- AAP and Bright Futures: Recommendations for Preventive Pediatric Health Care (updated February 2025)
- 42 U.S.C. 300gg-13: Coverage of preventive health services
- 42 U.S.C. 1396a: State plans for medical assistance
- 45 CFR 164.501: Definitions
- 45 CFR 164.502: Uses and disclosures of protected health information: General rules
- 45 CFR 164.508: Uses and disclosures for which an authorization is required
- 45 CFR 164.510: Uses and disclosures requiring an opportunity for the individual to agree or to object
- 15 U.S.C. 45: Unfair methods of competition unlawful
- 15 U.S.C. 52: Dissemination of false advertisements
- FTC: Health Products Compliance Guidance (December 2022)
- 16 CFR 251.1: Guide concerning use of the word free and similar representations
- 42 U.S.C. 1320a-7a: Civil monetary penalties
- 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
- 16 CFR 255.2: Consumer endorsements
- Google Ads: Personalized advertising policy
- U.S. Department of Justice: Guidance on Web Accessibility and the ADA
More in Physician specialty marketing